Magyar Hypertonia Társaság

Effect of intensive versus standard blood pressure control on cardiovascular outcomes in adult patients with hypertension: a systematic review and meta-analysis. 

Haze, T., Katsurada, K., Sakata, S. et al. 

Hypertens Res 48, 1846–1858 (2025). https://doi.org/10.1038/s41440-025-02131-0

Updated meta-analysis for antihypertensive treatment guided by home blood pressure compared to treatment based on office blood pressure: systematic review. 

Maruhashi, T., Tatsumi, Y., Satoh, M. et al. 

Hypertens Res 48, 1839–1845 (2025). https://doi.org/10.1038/s41440-024-02072-0

Association of Screenings for Hypertension, Diabetes, and High Cholesterol With All-Cause and Cardiovascular Mortality: Evidence From a Cohort Study

Jiayue Zhang, Shuting Wang, Ying Huang, Wenxiao Zheng, Ying Xiao, Zuyao Yang

J Clin Hypertens. Előzetes elektronikus közlés: 2025.05.06. https://doi.org/10.1111/jch.70053

Longitudinal blood pressure and cardiovascular outcomes in heart failure: An individual patient data pooling analysis of clinical trials

Li JW, Wang J, Chen Y, Yang H, Wang Y, Wang X, et al.

Eur J Heart Fail.Előzetes elektronikus közlés: 2025.05.24. doi: 10.1002/ejhf.3706.

Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers.

Lin RT, Gao JW, Yang YC, Chen XW, Gu ZJ, Tian LG,  et al.

J Hypertens. 2025;43(7):1214-1224. doi: 10.1097/HJH.0000000000004037

Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trial

Niki Procopi, Michel Zeitouni, Mathieu Kerneis, Guillaume Cayla, Emile Ferrari, et al. on behalf of the AβYSS Investigators of the ACTION Study Group 

European Heart Journal, előzetes elektronikus közlés: 2025.05.22. https://doi.org/10.1093/eurheartj/ehaf170

Resting heart rate – The forgotten risk factor? Comparison of resting heart rate and hypertension as predictors of all-cause mortality in 692,217 adults in Asia and Europe

Chi Pang Wen, Chien Hua Chen, Javaid Nauman, Jackson Pui Man Wai, Min Kuang Tsai, Jun-Han Lee, et al.

Progress in Cardiovascular Diseases 2025; 89: 35-44. https://doi.org/10.1016/j.pcad.2025.01.007

Impact of Daytime and Nighttime Blood Pressure and Nocturnal Blood Pressure Fall on Heart Failure Risk in Treated Hypertension

Francesca Coccina, Gil F Salles, Ramón C Hermida, José R Banegas, José M Bastos, Claudia R L Cardoso, et al.

American Journal of Hypertension 2025; 38(6): 361–369, https://doi.org/10.1093/ajh/hpaf008

Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization Studies

Nazarzadeh M,  Copland E, Byrne KS, Canoy D, Bidel Z, Woodward M, et al. Blood Pressure Lowering Treatment Trialists’ Collaboration

JACC: CardioOncology, előzetes elektronikus közlés: 2025.05.13. https://doi.org/10.1016/j.jaccao.2025.03.005

Heart rate-lowering drugs and outcomes in hypertension and/or cardiovascular disease: a meta-analysis

Sanidas E, Böhm M, Oikonomopoulou I, Dinopoulou P, Papadopoulos D, Michalopoulou H, et al.

European Heart Journal, előzetes elektronikus közlés: 2025.04.25. https://doi.org/10.1093/eurheartj/ehaf291